VolitionRX Q4 EPS $(0.11), Inline, Sales $243.97K Miss $450.00K Estimate
Portfolio Pulse from Happy Mohamed
VolitionRX (AMEX:VNRX) reported Q4 earnings with EPS of $(0.11), meeting analyst estimates, but missed sales forecasts with $243.97K versus the expected $450.00K. Despite the sales miss, this represents a significant increase over the previous year's figures.
March 25, 2024 | 8:28 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
VolitionRX reported Q4 EPS of $(0.11), in line with estimates, but missed revenue expectations with $243.97K against a $450.00K forecast. Year-over-year, sales have more than doubled.
While VolitionRX met EPS estimates, the significant miss on revenue forecasts could concern investors. However, the substantial year-over-year sales growth may offset some negative sentiment. The neutral score reflects the balance between these factors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100